Showing results (921-930 of 977) with videos related to
Sort By:
Pageof 98
NPJ Breast Cancer|December 12, 2025
Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment responseNanfizat A Alamukii, Anikó Kovács, Sukanya Raghavan, et al.NPJ Breast Cancer|December 14, 2025
Prognostic value of nuclear features based on tumor-associated collagen signatures in breast cancerZhijun Li, Deyong Kang, Chuan Wang, et al.NPJ Breast Cancer|November 7, 2025
Effects of acute exercise on inflammatory and metabolic biomarkers in women: a randomized controlled trialCatherine Duggan, Jean de Dieu Tapsoba, Jude Warner, et al.NPJ Breast Cancer|October 30, 2025
Association between ancestry and tumor somatic mutations in a large national cohort of women with breast cancerKirkpatrick B Fergus, Justin Newberg, Ray Greenstein, et al.NPJ Breast Cancer|November 5, 2025
Rewriting the radiation playbook: NSABP B-51 and the rise of pathologic precisionMehran Habibi, Bruce G Haffty, Silvia C FormentiNPJ Breast Cancer|November 4, 2025
Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancerVivek Anand, Bolutyfe Oderinde, Maryam Siddiqui, et al.NPJ Breast Cancer|July 10, 2025
Radiation therapy for lobular breast cancer: opportunities and challenges for leveraging radiosensitivityMichael R Boysen, Corey W Speers, Matthew J SikoraNPJ Breast Cancer|May 16, 2025
Unveiling the paradigm shift: systemic treatment strategies in small, node-negative breast cancerMariana Carvalho Gouveia, Mariana Scaranti, Bruna Migliavacca Zucchetti, et al.NPJ Breast Cancer|May 30, 2025
Development and characterisation of a novel 3D in vitro model of obesity-associated breast cancer as a tool for drug testingRhianna R R Blyth, Stèphanie A Laversin, Russell B Foxall, et al.NPJ Breast Cancer|May 24, 2025
Treatment patterns and clinical outcomes of patients with HER2-positive T1micN0 breast cancer: a single-center analysisCeline Yeh, Rachel Han, Abha Kulkarni, et al.Pageof 98